Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (191-200 of 999) with videos related to

Pageof 100
Sort By:
Journal of Lipid Research|January 13, 2012
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemiaAriel Brautbar, Salim S Virani, John Belmont, et al.
American Heart Journal|March 20, 2012
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging studyChristie M Ballantyne, Michael Miller, Eric J Niesor, et al.
Journal of the American College of Cardiology|July 12, 2014
Review of clinical practice guidelines for the management of LDL-related riskPamela B Morris, Christie M Ballantyne, Kim K Birtcher, et al.
Journal of Clinical Lipidology|February 22, 2023
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trialPaul M Ridker, Lei Lei, Kausik K Ray, et al.
Journal of Clinical Lipidology|December 10, 2013
Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndromeMadhuri Vasudevan, Urbain Tchoua, Baiba K Gillard, et al.
Genetic Epidemiology|March 29, 2002
LPL polymorphism predicts stroke risk in menAlanna C Morrison, Christie M Ballantyne, Molly Bray, et al.
Archives of Internal Medicine|May 16, 2000
Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination SurveyT A Jacobson, G G Griffiths, C Varas, et al.
American Journal of Hypertension|February 23, 2008
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC studyKelly A Volcik, Christie M Ballantyne, Michael C Braun, et al.
European Heart Journal|June 14, 2011
Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) studyVijay Nambi, Lloyd Chambless, Max He, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 31, 2012
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samplesOemer-Necmi Goek, Anna Köttgen, Ron C Hoogeveen, et al.
Pageof 100

Showing results (191-200 of 999) with videos related to

Sort By:
Pageof 100
Journal of Lipid Research|January 13, 2012
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemiaAriel Brautbar, Salim S Virani, John Belmont, et al.
American Heart Journal|March 20, 2012
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging studyChristie M Ballantyne, Michael Miller, Eric J Niesor, et al.
Journal of the American College of Cardiology|July 12, 2014
Review of clinical practice guidelines for the management of LDL-related riskPamela B Morris, Christie M Ballantyne, Kim K Birtcher, et al.
Journal of Clinical Lipidology|February 22, 2023
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trialPaul M Ridker, Lei Lei, Kausik K Ray, et al.
Journal of Clinical Lipidology|December 10, 2013
Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndromeMadhuri Vasudevan, Urbain Tchoua, Baiba K Gillard, et al.
Genetic Epidemiology|March 29, 2002
LPL polymorphism predicts stroke risk in menAlanna C Morrison, Christie M Ballantyne, Molly Bray, et al.
Archives of Internal Medicine|May 16, 2000
Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination SurveyT A Jacobson, G G Griffiths, C Varas, et al.
American Journal of Hypertension|February 23, 2008
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC studyKelly A Volcik, Christie M Ballantyne, Michael C Braun, et al.
European Heart Journal|June 14, 2011
Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) studyVijay Nambi, Lloyd Chambless, Max He, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 31, 2012
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samplesOemer-Necmi Goek, Anna Köttgen, Ron C Hoogeveen, et al.
Pageof 100